Jean-Pierre Kaiser

Dr. Jean-Pierre Kaiser


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in Biomaterials
Verified
Journal Article
Closed access
JKJean-Pierre Kaiser
Jean-Pierre Kaiser
ARAndreas Reinmann
Andreas Reinmann
ABArie Bruinink
Arie Bruinink

9 November 2012 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
SSStijn Smulders
Stijn Smulders
JKJean-Pierre Kaiser
Jean-Pierre Kaiser
SZStefano Zuin
Stefano Zuin
KLKirsten L Van Landuyt
Kirsten L Van Landuyt
LGLuana Golanski
Luana Golanski
PHPeter H.M. Hoet
Peter H.M. Hoet
Background: Nanomaterials can be contaminated with endotoxin (lipopolysaccharides, LPS) during production or handling. In this study, we searched for a convenient in vitro method to evaluate endotoxin contamination in nanoparticle samples. We assessed the reliability of the commonly used limulus amebocyte lysate (LAL) assay and an alternative method based on toll-like receptor (TLR) 4 reporter cells when applied with particles (TiO2, Ag, CaCO3 and SiO2), or after extraction of the endotoxin as described in the ISO norm 29701. Results: Our results indicate that the gel clot LAL assay is easily disturbed in the presence of nanoparticles; and that the endotoxin extraction protocol is not suitable at high particle concentrations. The chromogenic-based LAL endotoxin detection systems (chromogenic LAL assay and Endosafe-PTS), and the TLR4 reporter cells were not significantly perturbed. Conclusion: We demonstrated that nanoparticles can interfere with endotoxin detection systems indicating that a convenient test method must be chosen before assessing endotoxin contamination in nanoparticle samples.

Verified
Journal Article
Open access
PDF file
MRMatthias Roesslein
Matthias Roesslein
CHCordula Hirsch
Cordula Hirsch
JKJean-Pierre Kaiser
Jean-Pierre Kaiser
HKHarald F. Krug
Harald F. Krug
PWPeter Wick
Peter Wick
The release of reactive oxygen species (ROS) during the electron transport of mitochondrial aerobic respiration is the major source of ROS. However, contact between cells and nanoparticles (NPs) can also induce release of ROS, leading to an imbalance towards the pro-oxidative state. At low levels of ROS production, cells initiate a protective response to guarantee their survival, but an excess of ROS can damage cellular compounds such as membranes and various organelles, or directly cause genotoxicity. Thus an elevated level of ROS is an important indicator of cellular stress and an accurate recording of this parameter would be very informative. ROS can be measured by various assays, but all known assays measuring and quantifying ROS possess certain weaknesses. The problems and challenges of quantitatively detecting ROS in vitro using the 2',7'-dichlorodihydrofluorescein (DCF) assay is discussed as an example. In addition, we debate the difficulties in finding a suitable and stable chemical reaction control for the DCF assay (or other ROS-detecting assays). As a conclusion, we believe that using 3-morpholinosydnonimine hydrochloride (Sin-1) as a ROS inducer in the DCF assay is feasible only qualitatively. However, a quantitative measurement of the absolute amount of ROS produced and a quantitative comparison between experiments is (at the moment) impossible.

1 January 2013 in Science of The Total Environment
Verified
Journal Article
Closed access
JKJean-Pierre Kaiser
Jean-Pierre Kaiser
SZStefano Zuin
Stefano Zuin
PWPeter Wick
Peter Wick

8 November 2007 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
JKJean-Pierre Kaiser
Jean-Pierre Kaiser
PWPeter Wick
Peter Wick
PMPius Manser
Pius Manser
PSPhilipp Spohn
Philipp Spohn
ABArie Bruinink
Arie Bruinink

6 January 2017 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JKJean-Pierre Kaiser
Jean-Pierre Kaiser
MRMatthias Roesslein
Matthias Roesslein
LDLiliane Diener
Liliane Diener
AWAdrian Wichser
Adrian Wichser
BNBernd Nowack
Bernd Nowack
PWPeter Wick
Peter Wick
Nanosilver shows great promise for use in industrial, consumer or medical products because of its antimicrobial properties. However, the underlying mechanisms of the effects of silver nanoparticles on human cells are still controversial. Therefore, in the present study the influence of the chloride concentration and different serum content of culture media on the cytotoxic effects of nanosilver was systematically evaluated. Our results show that nanosilver toxicity was strongly affected by the composition of the culture media. The chloride concentration, as well as the carbon content affected the silver agglomeration and the complex formation. But also the dissolution of nanosilver and the availability of free silver ions (Ag+) were severely affected by the compositions of the culture media. Cells, only exposed to silver particles in suspension and dissolved silver complexes, did not show any effects under all conditions. Nanosilver agglomerates and silver complexes were not very soluble. Thus, cells growing on the bottom of the culture dishes were exposed to sedimented nanosilver agglomerates and precipitated silver complexes. Locally, the concentration of silver on the cell surface was very high, much higher compared the silver concentration in the bulk solution. The cytotoxic effects of nanosilver are therefore a combination of precipitated silver complexes and organic silver compounds rather than free silver ions. Silver coatings are used in health care products due to their bacteriostatic or antibacterial properties. The assessment of the toxicity of a certain compound is mostly done using in vitro assays. Therefore, cytotoxicity studies of nanosilver using human cell cultures have to be undertaken under well controlled and understood cultivations conditions in order to improve the compatibility of different studies. Especially when eukaryotic versus prokaryotic systems are compared for the evaluation of the use of nanosilver as antibacterial coatings for implants in order to prevent bacterial colonization.